Navigation Links
Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access
Date:4/3/2017

NORTH BRUNSWICK, N.J., April 3, 2017 /PRNewswire/ -- A retrospective review of 120 consecutive hemodialysis grafts placed in 98 patients was evaluated for patency and graft complications. Conducted between 2011 and 2014, the results were published in the March, 2017 Journal of Vascular Surgery, titled "Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access."

Initially presented at the 2015 symposium of the Society of Clinical Vascular Surgery, 52 grafts (43%) were Artegraft® Bovine Carotid Artery Graft™ (BCA) and 68 (57%) were ePTFE grafts from three major manufacturers.

In the review study, primary and primary assisted patencies were similar for BCA and ePTFE grafts. However, secondary patency was higher for BCA, indicating better durability for the biologic graft than for ePTFE grafts in patients whose anatomy precludes placement of an arteriovenous fistula (AVF).

Graft infection, steal and pseudoaneurysm rates were lower for BCA than for ePTFE.  There was a fivefold increase in mortality associated with ePTFE.

The study concluded that BCA is a durable alternative to AVF in contemporary practice.

About Artegraft
Incorporated in 1993, Artegraft Inc. offers surgeons a clinically proven biological alternative to synthetic grafts and an ideal repair and salvage conduit for a fistula.  Artegraft's natural collagen matrix has proven long-term patency advantages over ePTFE and other synthetic graft materials. Artegraft was the first vascular graft approved by the FDA in 1970 and has been in continuous clinical use for over 45 years. For more information, visit www.artegraft.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/retrospective-study-confirms-bovine-carotid-artery-biologic-graft-outperforms-expanded-polytetrafluoroethylene-for-hemodialysis-access-300433713.html


'/>"/>
SOURCE Artegraft
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Retrospective Study Examining Delcaths CHEMOSAT And Isolated Hepatic Perfusion Presented At ECCO Annual Meeting
2. Health 2.0 Unveils "10 Year Global Retrospective"
3. Advocacy Study Highlights Top Locations for High-Growth Companies
4. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
5. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
6. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
7. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
8. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
9. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
10. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
11. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Ky. , Sept. 19, 2017   ZirMed Inc ... predictive analytics, today announced that it has been ranked #1 ... Black Book™ Rankings 2017 User Survey. ZirMed was ... solution for large hospitals and medical centers over 200 beds ... Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Apple Rehab ... services, staged a mock evacuation of the facility as part of a disaster drill ... Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
Breaking Medicine News(10 mins):